Preliminary phase III efficacy and safety of alemtuzumab vs chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).

被引：0
|
作者：
Hillmen, P.
Skotnicki, A.
Robak, T.
Jaksic, B.
机构：
[1] Gen Infirm, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England
[2] Jagiellonian Univ, Coll Med, Krakow, Poland
[3] Kopernik Mem Hosp, Lodz, Poland
[4] Clin Hosp, Zagreb, Croatia
[5] Med Univ Lublin, Lublin, Poland
[6] Genzyme, Boston, MA USA
[7] Univ Hosp, Brno, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：339S / 339S
页数：1
相关论文
共 50 条
  • [41] CHEMOSENSITIVITY OF LYMPHOCYTES FROM PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA TO CHLORAMBUCIL, FLUDARABINE, AND CAMPTOTHECIN ANALOGS
    SILBER, R
    DEGAR, B
    COSTIN, D
    NEWCOMB, EW
    MANI, M
    ROSENBERG, CR
    MORSE, L
    DRYGAS, JC
    CANELLAKIS, ZN
    POTMESIL, M
    BLOOD, 1994, 84 (10) : 3440 - 3446
  • [42] Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
    Autore, Francesco
    Innocenti, Idanna
    Corrente, Francesco
    Del Principe, Maria Ilaria
    Rosati, Serena
    Falcucci, Paolo
    Fresa, Alberto
    Conte, Esmeralda
    Limongiello, Maria Assunta
    Renzi, Daniela
    De Padua, Laura
    Andriani, Alessandro
    Pisani, Francesco
    Cimino, Giuseppe
    Tafuri, Agostino
    Montanaro, Marco
    Mauro, Francesca Romana
    Del Poeta, Giovanni
    Laurenti, Luca
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
    Craig Reynolds
    Nicholas Di Bella
    Roger M. Lyons
    William Hyman
    Donald A. Richards
    Gerald J. Robbins
    Mark Vellek
    Kristi A. Boehm
    Feng Zhan
    Lina Asmar
    Investigational New Drugs, 2012, 30 : 1232 - 1240
  • [44] A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
    Reynolds, Craig
    Di Bella, Nicholas
    Lyons, Roger M.
    Hyman, William
    Richards, Donald A.
    Robbins, Gerald J.
    Vellek, Mark
    Boehm, Kristi A.
    Zhan, Feng
    Asmar, Lina
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1232 - 1240
  • [45] Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia
    Reynolds, Craig
    Di Bella, Nicholas
    Lyons, Roger M.
    Hyman, William J.
    Lee, Gary L.
    Richards, Donali A.
    Robbins, Gerald J.
    Vellek, Mark
    Boehm, Kristi A.
    Zhan, Feng
    Asmar, Lina
    BLOOD, 2008, 112 (11) : 126 - 126
  • [46] Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia
    Tefferi, A
    Levitt, R
    Li, CY
    Schroeder, G
    Tschetter, LK
    Michalak, JC
    Krook, JE
    Witzig, TE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 509 - 516
  • [47] Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia:: Results of a phase II trial
    Elter, T
    Borchmann, P
    Schulz, H
    Reiser, M
    Trelle, S
    Schnell, R
    Jensen, M
    Staib, P
    Schinköthe, T
    Stützer, H
    Rech, J
    Gramatzki, M
    Aulitzky, W
    Hasan, I
    Josting, A
    Hallek, M
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 7024 - 7031
  • [48] Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
    Kay, Neil E.
    Wu, Wenting
    Kabat, Brian
    LaPlant, Betsy
    Lin, Thomas S.
    Byrd, John C.
    Jelinek, Diane F.
    Greyer, Michael R.
    Zent, Clive S.
    Call, Timothy G.
    Shanafelt, Tait D.
    CANCER, 2010, 116 (09) : 2180 - 2187
  • [49] High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review
    Reljic, T.
    Kumar, A.
    Djulbegovic, B.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (08) : 1069 - 1074
  • [50] Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study
    Knauf, Wolfgang Ulrich
    Lissitchkov, Toshko
    Aldaoud, Ali
    Liberati, Anna
    Loscertales, Javier
    Herbrecht, Roul
    Juliusson, Gunnar
    Postner, Gerhard
    Gercheva, Liana
    Goranov, Stefan
    Becker, Martin
    Hoeffken, Klaus
    Huguet, Francoise
    Foa, Robert
    Merkle, Karlheinz
    Montillo, Marco
    BLOOD, 2008, 112 (11) : 728 - 728
12345